
Camosunate Paediatric (0–11 Months / Under 1 Year)
Prescription RequiredDelivery: Same-day in Lagos · up to 6 days nationwide
Free delivery on orders over ₦100,000
About Product:
Infant-formulated Artemisinin Combination Therapy Camosunate Paediatric (Artesunate 25mg + Amodiaquine 75mg) treats uncomplicated malaria in babies under 1 year.
Package Size:
QTY:
Buy once
Prescription medicines can't be set up for automatic refill.
90 - Day Buyer Protection
Money back guarantee
100% Quality Products
Buy top standard
Sanitized & Packaged Safely
Choose for contactless delivery
Things to know
Camosunate Paediatric (Under 1 Year) is a WHO-recommended oral Artemisinin-based Combination Therapy (ACT) specially formulated in flavored, easy-to-dissolve single-dose granules/powder for infants aged 0 to 11 months. Distributed in Nigeria by Geneith Pharmaceuticals Ltd, each pediatric sachet combines Artesunate (25 mg) and Amodiaquine base (75 mg) to rapidly clear malaria parasites from the bloodstream while preventing early recurrence. Designed for convenient 3-day once-daily administration without the need for refrigeration prior to mixing, Camosunate Paediatric provides effective, weight-appropriate antimalarial relief for infants.
Uses of Camosunate Paediatric (Under 1 Year)
Camosunate Paediatric (Under 1 Year) is doctor- and pharmacist-recommended for:
Treating acute, uncomplicated malaria caused by Plasmodium falciparum and other Plasmodium species (including chloroquine-resistant strains) in infants under 1 year of age.
Rapidly reducing fever, irritability, poor feeding, and parasite load in infants diagnosed with uncomplicated malaria.
Drugstore NigeriaProviding post-treatment protection against early malaria recrudescence due to amodiaquine's extended residence time.
Camosunate Paediatric (Under 1 Year) is a WHO-recommended oral Artemisinin-based Combination Therapy (ACT) specially formulated in flavored, easy-to-dissolve single-dose granules/powder for infants aged 0 to 11 months. Distributed in Nigeria by Geneith Pharmaceuticals Ltd, each pediatric sachet combines Artesunate (25 mg) and Amodiaquine base (75 mg) to rapidly clear malaria parasites from the bloodstream while preventing early recurrence. Designed for convenient 3-day once-daily administration without the need for refrigeration prior to mixing, Camosunate Paediatric provides effective, weight-appropriate antimalarial relief for infants.
Uses of Camosunate Paediatric (Under 1 Year)
Camosunate Paediatric (Under 1 Year) is doctor- and pharmacist-recommended for:
Treating acute, uncomplicated malaria caused by Plasmodium falciparum and other Plasmodium species (including chloroquine-resistant strains) in infants under 1 year of age.
Rapidly reducing fever, irritability, poor feeding, and parasite load in infants diagnosed with uncomplicated malaria.
Drugstore NigeriaProviding post-treatment protection against early malaria recrudescence due to amodiaquine's extended residence time.
Customer Reviews (0)
0.0/5.0
Best Selling Products
See allCheck these Out!
Didn't find your meds?
Chat with our pharmacist on WhatsApp and we'll help you find it.
Report any adverse drug reaction here
Report Now

















